Healthcare Times Utah: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Times Utah.

Press releases published on August 6, 2026

Aug. 6, 2026

Abeona Therapeutics® to Host Second Quarter 2026 Financial Results Conference Call on August 13, 2026

Indeterminate GlobeNewswire

Aug. 6, 2026

Compass Therapeutics Reports 2026 Second Quarter Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Aug. 6, 2026

BioVie Announces Topline Results of Phase 2 SUNRISE-PD Trial of Bezisterim in Early Parkinson’s Disease

Indeterminate GlobeNewswire

Aug. 6, 2026

Cronos Group Reports 2026 Second Quarter Results

Indeterminate GlobeNewswire

Aug. 6, 2026

Lexicon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Clinical Updates 

Indeterminate GlobeNewswire

Aug. 6, 2026

Cerenome Selects XiFin Empower RCM for Revenue Cycle Management and Clearinghouse Services for CNSide Platform

Indeterminate GlobeNewswire

Aug. 6, 2026

InflaRx Reports Second Quarter 2026 Results and Highlights Key Achievements and Expected Milestones

Indeterminate GlobeNewswire

Aug. 6, 2026

Alterity Therapeutics to Present at the 46th Annual Canaccord Genuity Growth Conference

Indeterminate GlobeNewswire

Aug. 6, 2026

Tarsus Reports Second Quarter 2026 Financial Results, Advances Next Phase of Growth

Indeterminate GlobeNewswire

Aug. 6, 2026

Ocugen Provides Business Update with Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 6, 2026

Tarsus Pharmaceuticals Announces Oversubscribed $125.0 Million Private Placement Equity Financing

Indeterminate GlobeNewswire

Aug. 6, 2026

Iovance Biotherapeutics Reports Record Second Quarter 2026 Revenue of ~$99M, Business Achievements, and Corporate Updates

Indeterminate GlobeNewswire

Aug. 6, 2026

Tarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals and Advance Eye Care Leadership Position

Indeterminate GlobeNewswire

Aug. 6, 2026

Immunocore reports second quarter financial results and provides a business update

Indeterminate GlobeNewswire

Aug. 6, 2026

Claret Capital Partners provides €30m financing to Carvolix to accelerate commercialization of medtech portfolio

Indeterminate GlobeNewswire

Aug. 6, 2026

Priovant Announces First Patients Enrolled in Phase 3 Study (BEACON+) of Brepocitinib in Cutaneous Sarcoidosis (CS)

Indeterminate GlobeNewswire

Aug. 6, 2026

Foghorn Therapeutics Provides Second Quarter 2026 Financial and Corporate Update

Indeterminate GlobeNewswire

Aug. 6, 2026

Opus Genetics Announces Financial Results for Second Quarter 2026 and Provides Corporate Update

Indeterminate GlobeNewswire

Aug. 6, 2026

Sionna Therapeutics Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 6, 2026

Cartesian Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire